Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

ClinicalTrials.gov ID: NCT06872125

Public ClinicalTrials.gov record NCT06872125. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 7:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

EMPEROR: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel Group, Phase 3 Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen (STK-001) in Patients With Dravet Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome.

Study identification

NCT ID
NCT06872125
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Stoke Therapeutics, Inc
Industry
Enrollment
170 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
2 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 4, 2025 (Actual)
Primary completion
Mar 2027 (Estimated)
Completion
Oct 2028 (Estimated)
Last update posted
Oct 20, 2026

2025 – 2028

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
26
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016 —
Arkansas Children's Hospital Little Rock Arkansas 72202 —
Cedars Sinai Medical Center Los Angeles California 90048 —
Children's Hospital of Orange County Orange California 92868 —
USCF Medical Center San Francisco California 94158 —
Children's Hospital Colorado Aurora Colorado 80045 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
Nemours Children's Health Jacksonville Florida 32207 —
Nicklaus Children's Hospital Miami Florida 33155 —
Advent Health Neuroscience Research Institute Orlando Florida 32804 —
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Boston Children's Hospital Boston Massachusetts 02115 —
CS Mott Children's Hospital Ann Arbor Michigan 48109 —
Mayo Clinic Rochester Minnesota 55905 —
NYU Langone Health New York New York 10016 —
Weill Cornell Medicine New York New York 10021 —
University of Rochester Medical Center Rochester New York 14642 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514 —
Duke University Health System Durham North Carolina 27705 —
Cleveland Clinic Cleveland Ohio 44195 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Oregon Health & Science University (OHSU) Portland Oregon 97239 —
LeBonheur Children's Hospital Memphis Tennessee 38103 —
Cook Children's Medical Center Fort Worth Texas 76104 —
Texas Children's Hospital Houston Texas 77030 —
University of Utah Primary Children's Hospital Salt Lake City Utah 84113 —
UVA Health Charlottesville Virginia 22903 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06872125, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06872125 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →